1. Home
  2. AVDL vs AZTA Comparison

AVDL vs AZTA Comparison

Compare AVDL & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • AZTA
  • Stock Information
  • Founded
  • AVDL 2015
  • AZTA 1978
  • Country
  • AVDL Ireland
  • AZTA United States
  • Employees
  • AVDL N/A
  • AZTA N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • AZTA Industrial Machinery/Components
  • Sector
  • AVDL Health Care
  • AZTA Technology
  • Exchange
  • AVDL Nasdaq
  • AZTA Nasdaq
  • Market Cap
  • AVDL 1.5B
  • AZTA 1.4B
  • IPO Year
  • AVDL 1996
  • AZTA 1995
  • Fundamental
  • Price
  • AVDL $18.57
  • AZTA $32.38
  • Analyst Decision
  • AVDL Buy
  • AZTA Buy
  • Analyst Count
  • AVDL 10
  • AZTA 4
  • Target Price
  • AVDL $18.94
  • AZTA $42.00
  • AVG Volume (30 Days)
  • AVDL 4.3M
  • AZTA 513.9K
  • Earning Date
  • AVDL 11-11-2025
  • AZTA 11-11-2025
  • Dividend Yield
  • AVDL N/A
  • AZTA N/A
  • EPS Growth
  • AVDL N/A
  • AZTA N/A
  • EPS
  • AVDL N/A
  • AZTA N/A
  • Revenue
  • AVDL $221,075,000.00
  • AZTA $668,821,000.00
  • Revenue This Year
  • AVDL $64.21
  • AZTA N/A
  • Revenue Next Year
  • AVDL $30.80
  • AZTA $4.10
  • P/E Ratio
  • AVDL N/A
  • AZTA N/A
  • Revenue Growth
  • AVDL 132.35
  • AZTA 12.46
  • 52 Week Low
  • AVDL $6.38
  • AZTA $23.91
  • 52 Week High
  • AVDL $18.65
  • AZTA $55.64
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 79.97
  • AZTA 57.45
  • Support Level
  • AVDL $13.83
  • AZTA $30.87
  • Resistance Level
  • AVDL $18.65
  • AZTA $32.45
  • Average True Range (ATR)
  • AVDL 0.59
  • AZTA 1.26
  • MACD
  • AVDL 0.43
  • AZTA 0.13
  • Stochastic Oscillator
  • AVDL 97.93
  • AZTA 81.84

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About AZTA Azenta Inc.

Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.

Share on Social Networks: